Hogarty, Michael D. http://orcid.org/0000-0002-9221-4852
Ziegler, David S.
Franson, Andrea http://orcid.org/0000-0002-5361-7683
Chi, Yueh-Yun
Tsao-Wei, Denice
Liu, Kangning
Vemu, Rohan
Gerner, Eugene W.
Bruckheimer, Elizabeth
Shamirian, Anasheh
Hasenauer, Beth
Balis, Frank M.
Groshen, Susan
Norris, Murray D. http://orcid.org/0000-0002-0632-4589
Haber, Michelle
Park, Julie R.
Matthay, Katherine K.
Marachelian, Araz
Funding for this research was provided by:
Alex’s Lemonade Stand Foundation for Childhood Cancer (REACH Award)
Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels (Scholar Award)
U.S. Department of Defense (CA1702571)
St. Baldrick’s Foundation (Research Award)
Australian Lions Childhood Cancer Research Foundation (Award, Award)
Kids Cancer Project
V Foundation for Cancer Research (Award, Award, Award)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA081403, CA081403, CA081403)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 10 October 2023
Revised: 22 November 2023
Accepted: 24 November 2023
First Online: 10 January 2024
Competing interests
: The authors declare no competing interests.
: This study was performed in accordance with the Declaration of Helsinki. Patients and/or legal guardians provided written informed consent. The Institutional Review Board of each New Approaches to Neuroblastoma Therapy (NANT) site approved the study. Mouse studies were done under an approved IACUC protocol at the Children’s Hospital of Philadelphia.
: Not applicable.